| PARP Inhibitor Efficacy Depends on CD8+ T-cell Recruitment via Intratumoral STING Pathway Activation in BRCA-Deficient Models of Triple-Negative Breast Cancer C Pantelidou, O Sonzogni, M De Oliveria Taveira, AK Mehta, A Kothari, ... Cancer discovery 9 (6), 722-737, 2019 | 490 | 2019 |
| Eukaryotic translation initiation factors in cancer development and progression R Spilka, C Ernst, AK Mehta, J Haybaeck Cancer letters 340 (1), 9-21, 2013 | 178 | 2013 |
| Targeting immunosuppressive macrophages overcomes PARP inhibitor resistance in BRCA1-associated triple-negative breast cancer AK Mehta, EM Cheney, CA Hartl, C Pantelidou, M Oliwa, JA Castrillon, ... Nature cancer 2 (1), 66-82, 2021 | 143 | 2021 |
| Macrophage biology and mechanisms of immune suppression in breast cancer AK Mehta, S Kadel, MG Townsend, M Oliwa, JL Guerriero Frontiers in immunology 12, 643771, 2021 | 95 | 2021 |
| Reduced mitochondrial apoptotic priming drives resistance to BH3 mimetics in acute myeloid leukemia S Bhatt, MS Pioso, EA Olesinski, B Yilma, JA Ryan, T Mashaka, B Leutz, ... Cancer cell 38 (6), 872-890. e6, 2020 | 84 | 2020 |
| Multiple screening approaches reveal HDAC6 as a novel regulator of glycolytic metabolism in triple-negative breast cancer CM Dowling, KER Hollinshead, A Di Grande, J Pritchard, H Zhang, ... Science advances 7 (3), eabc4897, 2021 | 38 | 2021 |
| Regulation of autophagy, NF-κB signaling, and cell viability by miR-124 in KRAS mutant mesenchymal-like NSCLC cells AK Mehta, K Hua, W Whipple, MT Nguyen, CT Liu, J Haybaeck, ... Science signaling 10 (496), eaam6291, 2017 | 27 | 2017 |
| High keratin 8/18 ratio predicts aggressive hepatocellular cancer phenotype N Golob-Schwarzl, K Bettermann, AK Mehta, SM Kessler, J Unterluggauer, ... Translational oncology 12 (2), 256-268, 2019 | 26 | 2019 |
| Keratin 18-deficiency results in steatohepatitis and liver tumors in old mice: A model of steatohepatitis-associated liver carcinogenesis K Bettermann, AK Mehta, EM Hofer, C Wohlrab, N Golob-Schwarzl, ... Oncotarget 7 (45), 73309, 2016 | 25 | 2016 |
| RETRACTED ARTICLE: Polymerase θ inhibition activates the cGAS-STING pathway and cooperates with immune checkpoint blockade in models of BRCA-deficient cancer J Patterson-Fortin, H Jadhav, C Pantelidou, T Phan, C Grochala, ... Nature Communications 14 (1), 1390, 2023 | 18 | 2023 |
| Comparing syngeneic and autochthonous models of breast cancer to identify tumor immune components that correlate with response to immunotherapy in breast cancer JC Lal, MG Townsend, AK Mehta, M Oliwa, E Miller, A Sotayo, E Cheney, ... Breast Cancer Research 23, 1-24, 2021 | 15 | 2021 |
| MEK and TAK1 regulate apoptosis in colon cancer cells with KRAS-dependent activation of proinflammatory signaling KL McNew, WJ Whipple, AK Mehta, TJ Grant, L Ray, C Kenny, A Singh Molecular cancer research 14 (12), 1204-1216, 2016 | 12 | 2016 |
| STK38L kinase ablation promotes loss of cell viability in a subset of KRAS-dependent pancreatic cancer cell lines TJ Grant, AK Mehta, A Gupta, AAD Sharif, KS Arora, V Deshpande, ... Oncotarget 8 (45), 78556, 2017 | 10 | 2017 |
| Diagnosis of tuberculosis: the experience at a specialized diagnostic laboratory A Mashta, P Mishra, S Philipose, S Tamilzhalagan, H Mahmud, S Bhaskar, ... Journal of Negative Results in BioMedicine 10, 1-7, 2011 | 6 | 2011 |
| Genetic variability, correlation and path coefficient study for various yield and quality traits in NPT lines of rice (Oryza sativa L.). N Surjaye, Y Singh, SK Singh, S Rahangdale, AK Mehta | 3 | 2022 |
| Una masa renal poco común en una adolescente–presentación de caso y revisión de la literatura JSS Galvis, DAC Arévalo, JMS Tovar Revista Urología Colombiana/Colombian Urology Journal 28 (04), 321-329, 2019 | 2 | 2019 |
| MiR-124 suppresses p62 and p65/NFkB to regulate autophagy, inflammation and cell death in KRAS mutant mesenchymal NSCLC cells AK Mehta, K Hua, W Whipple, MT Nguyen, RM Perera, J Haybaeck, ... Cancer Research 77 (13_Supplement), 2524-2524, 2017 | 2 | 2017 |
| Retraction Note: Polymerase θ inhibition activates the cGAS-STING pathway and cooperates with immune checkpoint blockade in models of BRCA-deficient cancer J Patterson-Fortin, H Jadhav, C Pantelidou, T Phan, C Grochala, ... nature communications 14 (1), 8193, 2023 | | 2023 |
| 982 Immune mediated mechanisms of PARPi resistance in BRCA1-associated triple negative breast cancer (TNBC) A Nelson, A Mehta, MG Townsend, M Oliwa, KF Zheng, PA Lee, ... Journal for ImmunoTherapy of Cancer 11 (Suppl 1), 2023 | | 2023 |
| 1111 Targeting lipid metabolism to improve PARP inhibitor response in BRCA-associated TNBC CW Wanderley, DE Michaud, K Kurmi, A Nelson, KF Zheng, S Joshi, ... Journal for ImmunoTherapy of Cancer 11 (Suppl 1), 2023 | | 2023 |
